Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis

Hepato-Gastroenterology

Volumn 44, Issue 13, 1997, Pages 90-107

  Niederau, Claus ^a   Backmerhoff, Frank ^a   Schumacher, Brigitte ^a   Niederau, Christoph ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Anti inflammatory mediators; Crohn's disease; Pro inflammatory mediators

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; MARKER; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MEDIATOR; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ACUTE-PHASE PROTEINS; ADULT; APOLIPOPROTEINS; C-REACTIVE PROTEIN; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; REGRESSION ANALYSIS; SERUM AMYLOID A PROTEIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031056803     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Cominelli F, Kam L. Inflammatory mediators of inflammatory bowel disease. Current Opinion in Gastroenterology 1993;9:534-43.
2. Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J 1989;8:3773-9.
3. Sipe JD, Johns MA, Ghezzi P, Knapschaefer G. Modulation of serum amyloid A gene expression by cytokines and bacterial cell wall components. Adv Exp Med Biol 1988;243:193-201.
4. Duclos B, Reimund JM, Lang JM, Coumaros G, Chamouard P, Lehr L, Baumann R, Koehl C, Weill JP. Elevated levels of soluble interleukin-2 receptors in Crohn's disease. Gastroenterol Clin Biol 1990;14:104-5.
5. Mahida Y, Wu K, Jewell DP. Enhanced production of interleukin-1α by mononuclear cells isolated from mucosa with active ulcerative colitis and Crohn's disease. Gut 1989;30:835-8.
6. Mazlam MZ, Hodgson HJF. Interrelations between interleukin-6, interleukin-1′Ω, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease. Gut 1994;35:77-83.
7. Brynskov J, Tvede N. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyctosporine. Gut 1990;31:795-9.
8. Dalekos GN, Manoussakis MN, Goussia AC, Tsianos EV, Moutsopoulos HM. Soluble interleukin-2 receptors, antineutrophil cytoplasmic antibodies, and other autoantibodies in patients with ulcerative colitis. Gut 1993;34:658-64.
9. Crabtree JE, Juby LD, Lobo AJ, Bullimore DW, Axon ATR. Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity. Gut 1990;31:1033-6.
10. Projansky R, Carpenter AB. Soluble interleukin-2 receptor as a marker of lymphocyte activation in childhood Crohn's disease. J Pediatr Gastroenterol Nutr 1991;13:277-84.
11. Mueller CH, Knoflach P, Zielinski CC. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 1990;98:639-46.
12. Gross V, Andus T, Ceasar I, Roth M, Schoelmerich J. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992;102:514-9.
13. Mahida YR, Kurlac L, Gallagher A, Hawkey CJ. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 1991;32:1531-4.
14. Maeda M, Watanabe N, Neda H, Yamauchi N, Okamoto T, Sasaki H, Tsuhi Y, Akiyama S, Tsuji N, Nitsu Y. Serum tumor necrosis factor activity in inflammatory bowel disease. Immunopharmical Immunotoxical 1992;14:451-61.
15. Schürmann G, Betzler M, Post S, Herfarth Ch, Meuer S. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1′Ω in patients with Crohn's disease and ulcerative colitis: Preoperative levels and postoperative changes of serum concentrations. Digestion 1992;51:51-9.
16. Matsuura T, West GA, Kleins JS, Ferraris L, Fiocchi L. Soluble interleukin-2 and CD8 and CD4 receptors in inflammatory bowel disease. Gastroenterology 1992;102:2006-14.
17. Mahida Y, Ceska M, Eggenberger F, Kurlak L, Lindley I, Hawkey CJ. Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci 1992;82:273-5.
18. Issacs K, Sartor RB, Haskill JS. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587-95.
19. Malizia G, Calabrese A, Cottone M, Raimondo M, Trejdosiewicz LK, Smart CJ, Oivia L, Pagliaro L. Expression of leucocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 1991;100:150-9.
20. Nielsen OH, Langholz E, Hendel J, Brynskov J. Circulating soluble intercellular adhesion molecule-1 (ICAM-1) in active inflammatory bowel disease. Dig Dis Sci 1994;39:1918-23.
21. Mozes G, Friedman N, Shainkin-Kesdtenbaum R. Serum amyloid A: an extremely sensitive marker of tissue damage in trauma patients and indicator of acute response in various diseases. J Trauma 1989;29:71-4.
22. Schultz D, Arnold P. Properties of four acute phase proteins: C-reactive protein, serum amyloid A, (1-acid glycoprotein and fibrinogen. Sem Arth Rheum 1990;20:129-47.
23. Best WB, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-44.
24. Gomes P, Boula CU, Smith CL, Holdstock G. Relationship between disease activity and colonoscopic findings in patients with colonic inflammtory bowel disease. Gut 1986; 27: 92-5.
25. Singleton JW. Clinical features, course and laboratory findings in ulcerative colitis; in Kirshner JB, Shorter RG (eds): Inflammatory Bowel Disease. Philadelphia, Lea & Febiger 1988; pp 167-83.
26. Truelove SC, Richards WCD. Biopsy studies in ulcerative colitis. Br Med J 1956; i: 4979-1315-8.
27. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2:1041-4
28. Byrkit, S.J.: Elements of statistics. Chapter 10: Analysis of variance. 3rd Edition. New York, van Nostrand Company, p. 305-58, 1980.
29. Duncan, D.B.: Multiple range tests for correlated and heteroscedastic: means. Biometrics 13:164-76, 1957.
30. Tukey JW. Exploratory data analysis. Reading, MA. Eddison-Wesley, 1987.
31. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
32. Hyams JS, Fitzgerald JE, Treem WR, Wyzga N, Kreutzer DL. Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease. Gastroenterology 1993;104:1285-92.
33. Mitsuyama K, Toyonaga A, Sasaki E, Ishida O, Ikeda ÆH, Tsuruta O, Harada K, Tateishi H, Nisiyama T, Tanikawa K. Soluble interleukin-6 receptors in inflammatory bowel disease: relations to circulation interleukin-6.
34. Gross V, Leser HG, Heinisch A, Schölmerich J. Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterol 1993; 40:522-30.
35. Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusuniko C, Otsuka K, Satoh S, Nima M, Senoh H, Fujiwara H. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and its protection by interleukin 6. J Exp Med 1994;179:1529-37.
36. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-33.
37. Osborn, L, Hession C, Tizard R, Vassallo C, Luhowskyj J, Chi-Rosso G, Lobb R. Direct expression cloning of vascular cell adhesion molecule-1, a cytokine inducible endothelial protein that binds to lymphocytes. Cell 1990;59:1203-11.
38. Cominelli F, Nast CC, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 1992; 103:65-71.
39. Moore KW, O'Garra A, DeWaal-Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-90.
40. Kühn R Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
41. Mullin GE, Vezza FR, Sampat A, Maycon Z, Kalz R, Eisenstein E, Katz S, Weissman G, McKinley M, Fisher SE. Abnormal IL-10 mRNA production in the intestinal mucosal lesions of inflammatory bowel disease. Gastroenterology 1993;104:A751.
42. Ishida H. Clinical implication of IL-10 in patients with immune and inflammatory disease. Jpn J Clin Pathol 1994;42:843-52.
43. van der Poll T, Jansen J, Levi M, ten Cate H, ten Cate JW, van Deventer SJH. Regulation of interleukin-10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 1994;180:1985-88.
44. Casini-Raggi V, Kam L, Chong YJT, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995;154:2434-40.
45. Mazlam MZ. Why measure C-reactive protein. Gut 1994;35:5-7.
46. Buckell NA, Lennard-Jones JE, Hernandez MA, Kohn J, Riches PG, Wadsworth J. Measurement of serum proteins during attacks of ulcerative colitis as a guide to patient management. Gut 1979;20:22-7.
47. Fagan EA, Dyck RF, Maton PN, Hodgson HJF, Chadwick VS, Petrie A. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1982;12:351-9.
48. Andre C, Descos L, Landais P, Fermanian J. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index. Gut 1981;22:571-4.
49. Gorevic PD, Rosenthal CJ, Franklin EC. Amyloid-related serum component (SAA) - studies in acute infections, medullary thyroid carcinoma, and post surgery behaviour as an acute phase reactant. Clin Immunol Immunopathol 1976;6:83-93.
50. Taylor AW, Ku N-O, Mortensen RF. Both IL-1 and Il-6 induce synthesis of C- reactive protein (CRP) by PLC/PRF/5 hepatoma cell line. Ann NY Acad Sci 1989;557:532-3.
51. McDonald TL, Weber A, Smith JW. A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein. J Immunol Methods 1991;144:149-55.
52. Morrow JF, Stearman RS, Peltzman CG, Potter DA. Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci USA 1981;78:4718-25.
53. Ganapathi MK, May LT, Schultz D, Brabenec A, Weinstein J, Sehgal PB, Kushner I. Role of interleukin-6 in regulating synthesis of C reactive protein and serum amyloid A in human hepatoma cell lines. Biochem Biophys Res Commun 1988;157:271-9.
54. Moshage HH, Roleofs HMJ, Van Pelt JF, Hazenberg BPC, Van Leeuwen MA, Lim- burg PC, Aarden LA, Yap SH. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun 1988;155:112-8.
55. Benson MD, Cohen AS. Serum amyloid A protein in amyloidosis, rheumatic and neoplastic diseases. Arthritis Rheum 1979;22:36-42.
56. Peristeris P, Gaspar A, Gros P, Laurent P, Bernon H, Bienvenu J. Effects of serum amyloid A. Protein on lymphocytes, HeLa, and MRC5 cells in culture. Biochem Cell Biol 1989;67:365-73.
57. Hocke G, Ebel H, Bittner K, Muller T, Kaffarnik H, Steinmetz A. A rapid laser immunonephelometric assay for serum amyloid A (SAA) and its application to the diagnosis of kidney allograft rejection. Klin Wochenschr 1989;67:447-51.
58. Maury CPJ, Teppo AM. Comparative study of serum amyloid related protein SAA, C-reactive protein and (2 microglobulin as markers of renal allograft rejection. Clin Nephrol 1984;22:284-9.
59. Marhaug G, Permin H, Husby G. Amyloid-related serum protein (SAA) as an indicator of lung infection in cystic fibrosis. Acta Paediatr Scand 1983;72:861-70.
60. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
61. Choukaife A, Visvikis S, Steinmetz J, Galteau MM, Kabbaj O, Ferard G, Metais P, Siest G. Two-dimensional electrophoresis of plasma proteins and high density lipoproteins during inflammation. Electrophoresis 1989;10:781-8.
62. Chambers RE, Stross P, Barry RE, Whicher JT. Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur J Clin Invest 1987;17:460-7.
63. De Beer FC, Mallya RK, Fagan EA, Lanham JG, Hughes GRV, Pepys MB. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet 1982;ii:231-4.
64. Mazlam MZ, Hodgson HJ. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 1992;33:773-8.
65. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S. Cytokine production in patients with inflammatory bowel disease. Gut 1992;33:933-7.
66. Brynskov J, Tvede N, Andersen CB, Vilien M. Increased concentrations of interleukin-1b, interleukin-2, and soluble interleukin-2 receptor in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992;33:55-8.